Tackling the Triple Transition in Global Health ProcurementJune 2019 read more
Publisher: Center for Global Development
Within a changing global health landscape, a forward-looking approach is needed to anticipate tomorrow’s challenges and plan for the future. To this end, the Center for Global Development convened the Working Group on the Future of Global Health Procurement to review the evidence and formulate recommendations for how the global health community—international health organizations, their bilateral and foundation donors, and low- and middle-income countries—can ensure the medium- to long-term relevance, efficiency, quality, affordability, and security of global health procurement. Importantly, the group limited its focus to the procurement process: the journey of a health product from manufacturer to a centralized warehouse or other wholesaling facility. The downstream supply chain and delivery process—a product’s journey from warehouse to end user—was beyond the Working Group’s scope.
The Challenges of Transition From Donor-Funded ProgramsJune 2019 read more
Publisher: Global Health: Science and Practice
In the era of declining development assistance for health, transitioning externally funded programs to governments becomes a priority for donors. However, the process requires a careful approach not only to preserve the public health gains that have already been achieved but also to expand on them. In the Eastern Europe and Central Asia region, countries are expected to graduate from support from the Global Fund to Fight AIDS, Tuberculosis and Malaria in or before 2025. We aim to describe transition risks and identify possible means to address them.
The economics of malaria control in an age of declining aidMay 2019 read more
Addressing the structural drivers of HIV: A STRIVE synthesisMay 2019 read more
The past two decades have seen significant progress in tackling HIV. Behavioural interventions have curbed rates of transmission. The scale up of HIV treatment has not only reduced levels of morbidity and mortality, but also created new opportunities for HIV prevention. However, mathematical modelling suggests that, with the current rate of antiretroviral therapy (ART) initiation, 49 million more new HIV infections will occur by 2035, and that even at best, with 90 to 95% coverage, treatment will avert only 60% of new infections.
The Future of the Global Fund’s Allocation Methodology 2020 – 2022
Publisher: Women4GlobalFund (W4GF)
This paper serves to provide an update W4GF Advocates on the Global Fund allocation methodology for the 2020-2022 funding cycle. It also seeks to highlight key recommendations from W4GF as the Global Fund continues to refine its allocation methodology.
Blended Finance in the Poorest Countries: The need for a better approach
The need to mobilise private finance is at the heart of international discussions on how to finance the Sustainable Development Goals (SDGs) and move the needle from ‘billions’ of dollars in development aid to ‘trillions’ of dollars in investment.
This report aims to provide hard evidence to inform the discussion on the role of blended finance in plugging the SDG financing gap in developing countries.
Financing Global Health 2018: Countries and Programs in Transition
Publisher: Institute for Health Metrics and Evaluation
This 10th edition of the Institute for Health Metrics and Evaluation’s annual Financing Global Health report provides the most up-to-date estimates of development assistance for health, domestic spending on health, health spending on two key infectious diseases – malaria and HIV/AIDS – and future scenarios of health spending. Several transitions in global health financing inform this report: the influence of economic development on the composition of health spending; the emergence of other sources of development assistance funds and initiatives; and the increased availability of disease-specific funding data for the global health community. For funders and policymakers with sights on achieving 2030 global health goals, these estimates are of critical importance. They can be used for identifying funding gaps, evaluating the allocation of scarce resources, and comparing funding across time and countries.
Global Health Spending and Development Assistance for Health
Publisher: Journal of the American Medical Association
In 2015, member states of the United Nations adopted the ambitious Sustainable Development Goals (SDGs), which included 17 global goals that targeted economic and social development.1 Goal 3, “to ensure healthy lives and promote well-being for all at all ages,” targets specifically marked progress in universal health coverage; improved access to safe, effective, and affordable medicines; and the end of the HIV, malaria, and tuberculosis epidemics by 2030.
Health Systems Performance in Managing Tuberculosis: Analysis of tuberculosis care cascades among high-burden and non-high burden countries
Publisher: Journal of Global Health
This study aims to analyze different patterns and gaps of care along the care cascade across countries and to develop a model to examine the relationship between performance of tuberculosis programmes in high and low burden countries along the tuberculosis care cascade and tuberculosis disease burden.
Global Summary of Findings of an Assessment of HIV Services Packages for Key Populations in Six Regions
Publisher: APMG Health, Inc. for GFAN
In 2017, the Global Fund contracted APMG Health to conduct assessments of the design, implementation, and monitoring of national HIV service packages for KP in 65 countries, across six regions in which the Global Fund has provided HIV grant funds. This report is a global-level analysis of those assessments.